PCN95 COST-EFFECTIVENESS OF BEVACIZUMAB COMBINATION THERAPY IN METASTATIC COLORECTAL CANCER- RESULTS OF MARKOV COHORT SIMULATION FROM A SOCIAL PERSPECTIVE IN KOREA
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74346-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)74346-1/fulltext
Title :
PCN95 COST-EFFECTIVENESS OF BEVACIZUMAB COMBINATION THERAPY IN METASTATIC COLORECTAL CANCER- RESULTS OF MARKOV COHORT SIMULATION FROM A SOCIAL PERSPECTIVE IN KOREA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74346-1&doi=10.1016/S1098-3015(10)74346-1
First page :
Section Title :
Open access? :
No
Section Order :
276